EUSA Pharma

EUSA Pharma

Pharmaceutical company developing and licensing late-stage oncology, pain control, and critical care products.

  • Edit
Get premium to view all results
DateInvestorsAmountRound
-investor investor investor investor investor investor investor investor investor investor investor

€0.0

round
investor investor

€0.0

round
investor investor investor investor

€0.0

round
N/A

€0.0

round
N/A

€0.0

round
N/A

€0.0

round
investor investor

€0.0

round

$680m

Acquisition
Total Funding000k

Financials

Estimates*

Get premium to view all results
Edit
Revenues, earnings & profits over time
GBP2016201720182019202020212022
Revenues0000000000000000000000000000
% growth16 %79 %66 %29 %106 %(20 %)8 %
EBITDA0000000000000000000000000000
% EBITDA margin-5 %79 %(1 %)18 %24 %12 %
Profit0000000000000000000000000000
% profit margin(26 %)(20 %)48 %(32 %)5 %4 %(3 %)
EV0000000000000000000000000000
EV / revenue00.0x00.0x00.0x00.0x00.0x00.0x00.0x
EV / EBITDA00.0x00.0x00.0x00.0x00.0x00.0x00.0x
R&D budget0000000000000000000000000000

Source: Company filings or news article

More about EUSA Pharma
Made with AI
Edit

EUSA Pharma is a dynamic, global specialty pharmaceutical company focused on developing and commercializing innovative medicines for oncology and rare diseases. The company serves patients worldwide, aiming to make a meaningful difference in their lives by providing access to life-changing treatments. EUSA Pharma operates in the pharmaceutical market, targeting both healthcare professionals and patients who require specialized therapies. The business model revolves around research and development, clinical trials, regulatory approvals, and the commercialization of its products. Revenue is generated through the sale of its pharmaceutical products, which are distributed globally. The company is committed to expanding its product portfolio and reaching more patients in need.

Keywords: oncology, rare diseases, innovative medicines, global distribution, clinical trials, regulatory approvals, patient-focused, specialty pharmaceuticals, healthcare professionals, life-changing treatments.

Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.
Book a Demo

Investments by EUSA Pharma

Edit
Cytogen Corporation
ACQUISITION by EUSA Pharma May 2008